These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16765261)

  • 61. Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.
    Atik B; Johnston SC; Dean D
    PLoS One; 2010 Jun; 5(6):e11026. PubMed ID: 20543948
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chlamydia pneumoniae and atherosclerosis.
    Rutherford JD
    Curr Atheroscler Rep; 2000 May; 2(3):218-25. PubMed ID: 11122747
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chlamydia pneumoniae in atherosclerotic lesions of patients undergoing vascular surgery.
    Loehe F; Bittmann I; Weilbach C; Lauterjung L; Schildberg FW; Heiss MM
    Ann Vasc Surg; 2002 Jul; 16(4):467-73. PubMed ID: 12098020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis?
    Kuo C; Campbell LA
    Mol Med Today; 1998 Oct; 4(10):426-30. PubMed ID: 9793930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis.
    Kreutmayer S; Csordas A; Kern J; Maass V; Almanzar G; Offterdinger M; Öllinger R; Maass M; Wick G
    Cell Stress Chaperones; 2013 May; 18(3):259-68. PubMed ID: 23192457
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Value of animal models for Chlamydia pneumoniae-related atherosclerosis.
    Fong IW
    Am Heart J; 1999 Nov; 138(5 Pt 2):S512-3. PubMed ID: 10539861
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque.
    Bobryshev YV; Killingsworth MC; Tran D; Lord R
    Virchows Arch; 2008 Jul; 453(1):69-77. PubMed ID: 18528704
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.
    Di Pietro M; Filardo S; De Santis F; Sessa R
    Int J Mol Sci; 2013 Jul; 14(7):15105-20. PubMed ID: 23877837
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae.
    Maass M; Gieffers J; Solbach W
    Herz; 2000 Mar; 25(2):68-72. PubMed ID: 10829241
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association of Chlamydia pneumoniae Infection With Atherosclerotic Plaque Formation.
    Assar O; Nejatizadeh A; Dehghan F; Kargar M; Zolghadri N
    Glob J Health Sci; 2015 Sep; 8(4):260-7. PubMed ID: 26573036
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease.
    Girard SE; Temesgen Z
    Expert Opin Pharmacother; 2001 May; 2(5):765-72. PubMed ID: 11336621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chlamydial infection in canine atherosclerotic lesions.
    Sako T; Takahashi T; Takehana K; Uchida E; Nakade T; Umemura T; Taniyama H
    Atherosclerosis; 2002 Jun; 162(2):253-9. PubMed ID: 11996944
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.
    Gieffers J; Füllgraf H; Jahn J; Klinger M; Dalhoff K; Katus HA; Solbach W; Maass M
    Circulation; 2001 Jan; 103(3):351-6. PubMed ID: 11157684
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Infection and coronary heart disease.
    Ellis RW
    J Med Microbiol; 1997 Jul; 46(7):535-9. PubMed ID: 9236736
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Retinoic acid prevents Chlamydia pneumoniae-induced foam cell development in a mouse model of atherosclerosis.
    Jiang SJ; Campbell LA; Berry MW; Rosenfeld ME; Kuo CC
    Microbes Infect; 2008 Oct; 10(12-13):1393-7. PubMed ID: 18678272
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice.
    Blessing E; Campbell LA; Rosenfeld ME; Kuo CC
    Infect Immun; 2002 Sep; 70(9):5332-4. PubMed ID: 12183595
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions.
    Kalayoglu MV; Indrawati ; Morrison RP; Morrison SG; Yuan Y; Byrne GI
    J Infect Dis; 2000 Jun; 181 Suppl 3():S483-9. PubMed ID: 10839744
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen.
    Jackson LA; Campbell LA; Kuo CC; Rodriguez DI; Lee A; Grayston JT
    J Infect Dis; 1997 Jul; 176(1):292-5. PubMed ID: 9207386
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice.
    Blessing E; Campbell LA; Rosenfeld ME; Chough N; Kuo CC
    Atherosclerosis; 2001 Sep; 158(1):13-7. PubMed ID: 11500169
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The relationship between Chlamydia pneumoniae and atherosclerosis].
    Gayet A; Baril L; Orfila J
    Presse Med; 2001 Dec; 30(36):1792-801. PubMed ID: 11771205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.